GLP-1 Drugs Tied to Lower Risk of Legal Blindness in People With Diabetes



(MedPage Today) — ORLANDO — Adding another twist to the ongoing debate about the effects of weight-loss drugs on vision, a retrospective cohort study linked GLP-1 receptor agonists to a lower risk of legal blindness in patients with type 2…



Source link : https://www.medpagetoday.com/meetingcoverage/aao/118068

Author :

Publish date : 2025-10-21 19:03:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version